General Proximity is a seed stage biotechnology platform company founded in 2019 to pioneer the next generation of induced proximity medicines for undruggable targets.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/03/25 | $16,000,000 |
age1 Ben Mann Felicis Ventures  Jeff Dean Modi Ventures Uri Lopatin Wilson Sonsini Investments | undisclosed |
